Brief: Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference
07/01/2026 22:09
Jan 8 (Reuters) - Terns Pharmaceuticals Inc TERN.O: TERNS PHARMACEUTICALS TO HIGHLIGHT 2026 PRIORITIES AND PROGRAM MILESTONES AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE Source text: ID:nGNX8Q0KR6 Further company coverage: TERN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Terns Pharmaceuticals
See all newsNASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. RESEARCH ROUNDUP-East West Bancorp, Reliance, S&P Global
Brief: Merck Announces Expiration Of Hart-Scott-Rodino Act Waiting Period To Acquire Terns Pharmaceuticals
Brief: Merck Begins Tender Offer To Acquire Terns Pharmaceuticals, Inc.